1921
Volume 97, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.17-0373
2017-08-02
2018-11-17
Loading full text...

Full text loading...

/deliver/fulltext/14761645/97/2/tpmd170373.html?itemId=/content/journals/10.4269/ajtmh.17-0373&mimeType=html&fmt=ahah

References

  1. Saunders D, Vanachayangkul P, Lon C, , 2014. Dihydroartemisinin-piperaquine failure in Cambodia. N Engl J Med 371: 484485.[Crossref]
  2. Burrows JN, Duparc S, Gutteridge WE, , Hooft van Huijsduijnen R, Kaszubska W, Macintyre F, Mazzuri S, Möhrle JJ, Wells TNC, 2017. New developments in anti-malarial target candidate and product profiles. Malar J 16: 26.[Crossref]
  3. Leong FJ, Li R, Jain JP, Lefèvre G, Magnusson B, Diagana TT, Pertel P, , 2014. A first-in-human randomized, double-blind, placebo-controlled, single-and multiple-ascending oral dose study of novel antimalarial Spiroindolone KAE609 (Cipargamin) to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers. Antimicrob Agents Chemother 58: 62096214.[Crossref]
  4. Charman SA, Arbe-Barnes S, Bathurst IC, , Brun R, Campbell M, Charman WN, Chiu FC, Chollet J, Craft JC, Creek DJ, Dong Y, Matile H, Maurer M, Morizzi J, Nguyen T, Papastogiannidis P, Scheurer C, Shackleford DM, Sriraghavan K, Stingelin L, Tang Y, Urwyler H, Wang X, White KL, Wittlin S, Zhou L, Vennerstrom JL, 2011. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria. Proc Natl Acad Sci USA 108: 44004405.[Crossref]
  5. Lon C, Manning J, Vanachayangkul P, , So M, Sea D, Se Y, Gosi P, Lanteri C, Chaorattanakawee S, Sriwichai S, Chann S, Kuntawunginn W, Buathong N, Nou S, Walsh DS, Tyner SD, Juliano JJ, Lin J, Spring M, Bethell D, Kaewkungwal J, Tang D, Chuor CM, Satharath P, Saunders D, 2014. Efficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trial. PLoS One 9: e93138.[Crossref]
  6. Vanachayangkul P, Lon C, Spring M, , Sok S, Ta-Aksorn W, Kodchakorn C, Pann ST, Chann S, Ittiverakul M, Sriwichai S, Buathong N, Kuntawunginn W, So M, Youdaline T, Milner E, Wojnarski M, Lanteri C, Manning J, Prom S, Haigney M, Cantilena L, Saunders D, 2017. Piperaquine population pharmacokinetics and cardiac safety in Cambodia. Antimicrob Agents Chemother 61: e02000e02016.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.17-0373
Loading
  • Received : 10 May 2017
  • Accepted : 11 May 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error